Cellebrite’s full 2025 annual report lands in SEC filing - Stock Titan

Cellebrite Files its 2025 Annual Report on Form 20-F Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Cellebrite (Nasdaq: CLBT) filed its Annual Report on Form 20-F for the year ended December 31, 2025 on March 4, 2026. The filing is available on the company's investor relations website and the U.S. SEC website. Shareholders can request a free hard copy by emailing investors@cellebrite.com. References to external websites or social media do not constitute incorporation by reference into this release. News Market Reaction – CLBT +3.02% 29 alerts +3.02% NEWS EFFECT +3.5% PEAK IN 5 HR 27 MIN +$112M VALUATION IMPACT $3.81B MARKET CAP 0.7x REL. VOLUME On the day this news was published, CLBT gained 3.02%, reflecting a moderate positive market reaction. Argus tracked a peak move of +3.5% during that session. Our momentum scanner triggered 29 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $112M to the company's valuation, bringing the market cap to $3.81B at that time. Data tracked by StockTitan Argus on the day of publication. Key Figures Report year: 2025 Year-end date: December 31, 2025 Press release date: March 4, 2026 3 metrics REPORT YEAR 2025 Annual Report on Form 20-F year referenced in filing YEAR-END DATE December 31, 2025 Fiscal year end covered by the Form 20-F PRESS RELEASE DATE March 4, 2026 Date of announcement regarding Form 20-F filing Market Reality Check Price: $14.69 Vol: Volume 1,491,215 vs 20-da... low vol $14.69 LAST CLOSE VOLUME Volume 1,491,215 vs 20-day average 2,416,215, indicating lighter-than-normal trading. LOW TECHNICAL Shares at 13.745, trading below the 200-day MA of 16.49 and 34.11% under the 52-week high. Peers on Argus CLBT gained 1.81% while several software peers like AVPT, BOX, PAY and QLYS were... 3 Up CLBT gained 1.81% while several software peers like AVPT, BOX, PAY and QLYS were also positive, but momentum scanner flags only a few names (e.g., BOX, CORZ, STNE) with stronger upside, suggesting today’s move is more stock-specific than a broad sector rotation. Historical Context 5 past events · Latest: Mar 02 (Positive) Pattern 5 events DATE EVENT SENTIMENT MOVE CATALYST Mar 02 Acquisition completion Positive +1.2% Closed SCG Canada deal to add UAV/drone forensic capabilities. Feb 24 Conference participation Positive +5.8% Announced participation in Morgan Stanley TMT conference fireside chat. Feb 11 Earnings results Positive -4.5% Reported record Q4 and FY 2025 metrics and 2026 growth guidance. Feb 05 Industry report Positive -2.6% Released 2026 industry trends report on digital evidence and AI adoption. Jan 21 Earnings date set Neutral -3.9% Announced date and time for Q4 and FY 2025 results call. PATTERN DETECTED Recent news flow mixed operational updates, M&A and investor events. Strong fundamental releases (record 2025 results) did not always translate into positive one-day moves, while conference participation and small acquisitions saw modest gains, indicating event-type dependent reactions. RECENT COMPANY HISTORY Over the last few months, Cellebrite has reported record Q4/FY 2025 results, outlined strong ARR and revenue growth, and announced acquisitions such as Corellium and SCG Canada. Investor events, including the Feb 11, 2026 earnings call and a Morgan Stanley conference appearance on Mar 3, 2026, have kept visibility high. The prior acquisition of SCG Canada on Mar 2, 2026 and industry trend reporting built a narrative of expansion. Today’s Form 20-F filing fits into this ongoing disclosure and reporting cadence. Market Pulse Summary This announcement centers on Cellebrite’s filing of its 2025 Annual Report on Form 20-F for the year... Analysis This announcement centers on Cellebrite’s filing of its 2025 Annual Report on Form 20-F for the year ended December 31, 2025. It formalizes and consolidates recently disclosed operating and financial details for regulators and shareholders. In the context of recent record results, acquisitions, and active SEC reporting, this filing continues a steady disclosure cadence. Investors may focus on any new risk factors, business segment details, and updated share count or governance information highlighted within the full Form 20-F document. Key Terms form 20-f, u.s. securities and exchange commission, incorporation by reference 3 terms Form 20-F REGULATORY U.S. Securities And Exchange Commission REGULATORY Incorporation By Reference REGULATORY AI-generated analysis. Not financial advice. 03/04/2026 - 08:30 AM TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 4, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC"). Cellebrite's 2025 Annual Report on Form 20-F is available on the investor relations section of its website at https://investors.cellebrite.com/financial-information/sec-filings and on the SEC's website at www.sec.gov. Shareholders may request a hard copy of the 2025 Annual Report on Form 20-F, free of charge, by contacting the Company at investors@cellebrite.com. References to Websites and Social Media Platforms References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release. About Cellebrite Cellebrite's (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite's AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite's technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com. Investor Relations Andrew Kramer Vice President, Investor Relations investors@cellebrite.com +1 973.206.7760 Media Victor Cooper Sr. Director of Corporate Communications + Content Operations Victor.cooper@cellebrite.com +1 404.804.5910 SOURCE Cellebrite FAQ When did Cellebrite (CLBT) file its 2025 Annual Report on Form 20-F? Cellebrite filed its 2025 Annual Report on Form 20-F on March 4, 2026. According to the company, the report covers the year ended December 31, 2025 and is available on the company's investor relations website and the U.S. SEC EDGAR database for shareholder review. Where can investors access Cellebrite's (CLBT) 2025 Form 20-F filing? Investors can access Cellebrite's 2025 Form 20-F on the company's investor relations website and on the U.S. SEC website. According to the company, the filing is posted at https://investors.cellebrite.com/financial-information/sec-filings and on www.sec.gov for public download and available free of charge. Can shareholders request a hard copy of Cellebrite's 2025 Form 20-F (CLBT)? Yes. Shareholders may request a free hard copy of Cellebrite's 2025 Form 20-F by contacting the company at investors@cellebrite.com. According to the company, the copy is provided free of charge and instructions are available via the investor relations contact email. Does the 2025 Form 20-F for Cellebrite (CLBT) cover the fiscal year ended December 31, 2025? Yes. The 2025 Form 20-F covers the fiscal year ended December 31, 2025. According to the company, the annual report consolidates disclosures for that year and is filed with the U.S. SEC to satisfy reporting obligations for Nasdaq-listed international issuers. Will Cellebrite's 2025 Form 20-F include audited financial statements for investors to review (CLBT)? Yes. The Form 20-F typically includes audited financial statements and required disclosures for the year. According to the company, the 2025 filing is available on the investor relations site and on the SEC website, where the financial statements and notes can be reviewed by investors. How does filing the 2025 Form 20-F affect Cellebrite's (CLBT) compliance and investor transparency? Filing the 20-F maintains regulatory compliance and public disclosure obligations for foreign issuers. According to the company, the 2025 Form 20-F fulfills reporting duties to the U.S. SEC, supports investor transparency, and makes audited disclosures accessible to shareholders and analysts for evaluation.